Specificity and mechanism(s) of promoter inhibitors in multistage promotion.
D000818:Animals; D002273:Carcinogens / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D003043:Cocarcinogenesis; D004224:Diterpenes; D000078404:Epidermal Cells; D005446:Fluocinolone Acetonide / Q000494:pharmacology; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009955:Ornithine Decarboxylase / Q000378:metabolism; D010703:Phorbol Esters / Q000494:pharmacology; D011073:Polyamines / Q000378:metabolism; D012878:Skin Neoplasms / Q000139:chemically induced*; D013729:Terpenes; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014108:Tosylphenylalanyl Chloromethyl Ketone / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology
D002273:Carcinogens; D004224:Diterpenes; D010703:Phorbol Esters; D011073:Polyamines; D013729:Terpenes; D005446:Fluocinolone Acetonide; C011309:mezerein; D014108:Tosylphenylalanyl Chloromethyl Ketone; D014212:Tretinoin; D009955:Ornithine Decarboxylase; D013755:Tetradecanoylphorbol Acetate